Compare RGEN & AYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGEN | AYI |
|---|---|---|
| Founded | 1981 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Building Products |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0B | 9.6B |
| IPO Year | 1995 | 2001 |
| Metric | RGEN | AYI |
|---|---|---|
| Price | $178.78 | $297.08 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 22 | 7 |
| Target Price | $197.95 | ★ $375.17 |
| AVG Volume (30 Days) | ★ 1.2M | 372.8K |
| Earning Date | 10-27-2026 | 10-01-2026 |
| Dividend Yield | N/A | ★ 0.27% |
| EPS Growth | ★ 286.96 | N/A |
| EPS | 0.24 | ★ 11.45 |
| Revenue | $141,236,000.00 | ★ $3,461,000,000.00 |
| Revenue This Year | $12.87 | $3.87 |
| Revenue Next Year | $29.67 | $4.97 |
| P/E Ratio | $743.42 | ★ $25.87 |
| Revenue Growth | ★ 35.10 | 4.05 |
| 52 Week Low | $100.99 | $257.04 |
| 52 Week High | $198.87 | $380.17 |
| Indicator | RGEN | AYI |
|---|---|---|
| Relative Strength Index (RSI) | 51.87 | 39.79 |
| Support Level | $159.22 | $294.47 |
| Resistance Level | $188.73 | $300.73 |
| Average True Range (ATR) | 8.81 | 8.35 |
| MACD | -1.51 | 0.22 |
| Stochastic Oscillator | 52.38 | 12.70 |
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.
Acuity is a leading industrial technology company that offers lighting, lighting controls, and intelligent building solutions. It designs, manufactures, and brings to market products and services relating to these and other offerings. Acuity has two reportable segments: Acuity Brands Lighting and Acuity Intelligent Spaces. ABL sells commercial, architectural, and specialty lighting, including components and control systems. AIS offers building management and audio/visual solutions to help make buildings intelligent.